Report Cover

Global and Japan Anti-Migraine Drugs Market Insights, Forecast to 2026


Anti-Migraine Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Anti-Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Anti-Migraine Drugs market is segmented into
    Triptans
    Ergots
    Others

Segment by Application, the Anti-Migraine Drugs market is segmented into
    Women
    Men

Regional and Country-level Analysis
The Anti-Migraine Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-Migraine Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Anti-Migraine Drugs Market Share Analysis
Anti-Migraine Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-Migraine Drugs business, the date to enter into the Anti-Migraine Drugs market, Anti-Migraine Drugs product introduction, recent developments, etc.
The major vendors covered:
    Eli Lilly
    Abbott Laboratories
    Eisai
    Allergan
    Endo
    GlaxoSmithKline
    Impax Laboratories
    Pfizer
    AstraZeneca
    Bayer
    Johnson & Johnson
    Merck
    Teva
    Amgen
1 Study Coverage
    1.1 Anti-Migraine Drugs Product Introduction
    1.2 Market Segments
    1.3 Key Anti-Migraine Drugs Manufacturers Covered: Ranking by Revenue
    1.4 Market by Type
        1.4.1 Global Anti-Migraine Drugs Market Size Growth Rate by Type
        1.4.2 Triptans
        1.4.3 Ergots
        1.4.4 Others
    1.5 Market by Application
        1.5.1 Global Anti-Migraine Drugs Market Size Growth Rate by Application
        1.5.2 Women
        1.5.3 Men
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Anti-Migraine Drugs Market Size, Estimates and Forecasts
        2.1.1 Global Anti-Migraine Drugs Revenue 2015-2026
        2.1.2 Global Anti-Migraine Drugs Sales 2015-2026
    2.2 Global Anti-Migraine Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    2.3 Anti-Migraine Drugs Historical Market Size by Region (2015-2020)
        2.3.1 Global Anti-Migraine Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
        2.3.2 Global Anti-Migraine Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
    2.4 Anti-Migraine Drugs Market Estimates and Projections by Region (2021-2026)
        2.4.1 Global Anti-Migraine Drugs Sales Forecast by Region (2021-2026)
        2.4.2 Global Anti-Migraine Drugs Revenue Forecast by Region (2021-2026)

3 Global Anti-Migraine Drugs Competitor Landscape by Players
    3.1 Global Top Anti-Migraine Drugs Sales by Manufacturers
        3.1.1 Global Anti-Migraine Drugs Sales by Manufacturers (2015-2020)
        3.1.2 Global Anti-Migraine Drugs Sales Market Share by Manufacturers (2015-2020)
    3.2 Global Anti-Migraine Drugs Manufacturers by Revenue
        3.2.1 Global Anti-Migraine Drugs Revenue by Manufacturers (2015-2020)
        3.2.2 Global Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020)
        3.2.3 Global Anti-Migraine Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
        3.2.4 Global Top 10 and Top 5 Companies by Anti-Migraine Drugs Revenue in 2019
        3.2.5 Global Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Global Anti-Migraine Drugs Price by Manufacturers
    3.4 Global Anti-Migraine Drugs Manufacturing Base Distribution, Product Types
        3.4.1 Anti-Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Anti-Migraine Drugs Product Type
        3.4.3 Date of International Manufacturers Enter into Anti-Migraine Drugs Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
    4.1 Global Anti-Migraine Drugs Market Size by Type (2015-2020)
        4.1.1 Global Anti-Migraine Drugs Sales by Type (2015-2020)
        4.1.2 Global Anti-Migraine Drugs Revenue by Type (2015-2020)
        4.1.3 Anti-Migraine Drugs Average Selling Price (ASP) by Type (2015-2026)
    4.2 Global Anti-Migraine Drugs Market Size Forecast by Type (2021-2026)
        4.2.1 Global Anti-Migraine Drugs Sales Forecast by Type (2021-2026)
        4.2.2 Global Anti-Migraine Drugs Revenue Forecast by Type (2021-2026)
        4.2.3 Anti-Migraine Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
    4.3 Global Anti-Migraine Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
    5.1 Global Anti-Migraine Drugs Market Size by Application (2015-2020)
        5.1.1 Global Anti-Migraine Drugs Sales by Application (2015-2020)
        5.1.2 Global Anti-Migraine Drugs Revenue by Application (2015-2020)
        5.1.3 Anti-Migraine Drugs Price by Application (2015-2020)
    5.2 Anti-Migraine Drugs Market Size Forecast by Application (2021-2026)
        5.2.1 Global Anti-Migraine Drugs Sales Forecast by Application (2021-2026)
        5.2.2 Global Anti-Migraine Drugs Revenue Forecast by Application (2021-2026)
        5.2.3 Global Anti-Migraine Drugs Price Forecast by Application (2021-2026)

6 Japan by Players, Type and Application
    6.1 Japan Anti-Migraine Drugs Market Size YoY Growth 2015-2026
        6.1.1 Japan Anti-Migraine Drugs Sales YoY Growth 2015-2026
        6.1.2 Japan Anti-Migraine Drugs Revenue YoY Growth 2015-2026
        6.1.3 Japan Anti-Migraine Drugs Market Share in Global Market 2015-2026
    6.2 Japan Anti-Migraine Drugs Market Size by Players (International and Local Players)
        6.2.1 Japan Top Anti-Migraine Drugs Players by Sales (2015-2020)
        6.2.2 Japan Top Anti-Migraine Drugs Players by Revenue (2015-2020)
    6.3 Japan Anti-Migraine Drugs Historic Market Review by Type (2015-2020)
        6.3.1 Japan Anti-Migraine Drugs Sales Market Share by Type (2015-2020)
        6.3.2 Japan Anti-Migraine Drugs Revenue Market Share by Type (2015-2020)
        6.3.3 Japan Anti-Migraine Drugs Price by Type (2015-2020)
    6.4 Japan Anti-Migraine Drugs Market Estimates and Forecasts by Type (2021-2026)
        6.4.1 Japan Anti-Migraine Drugs Sales Forecast by Type (2021-2026)
        6.4.2 Japan Anti-Migraine Drugs Revenue Forecast by Type (2021-2026)
        6.4.3 Japan Anti-Migraine Drugs Price Forecast by Type (2021-2026)
    6.5 Japan Anti-Migraine Drugs Historic Market Review by Application (2015-2020)
        6.5.1 Japan Anti-Migraine Drugs Sales Market Share by Application (2015-2020)
        6.5.2 Japan Anti-Migraine Drugs Revenue Market Share by Application (2015-2020)
        6.5.3 Japan Anti-Migraine Drugs Price by Application (2015-2020)
    6.6 Japan Anti-Migraine Drugs Market Estimates and Forecasts by Application (2021-2026)
        6.6.1 Japan Anti-Migraine Drugs Sales Forecast by Application (2021-2026)
        6.6.2 Japan Anti-Migraine Drugs Revenue Forecast by Application (2021-2026)
        6.6.3 Japan Anti-Migraine Drugs Price Forecast by Application (2021-2026)

7 North America
    7.1 North America Anti-Migraine Drugs Market Size YoY Growth 2015-2026
    7.2 North America Anti-Migraine Drugs Market Facts & Figures by Country
        7.2.1 North America Anti-Migraine Drugs Sales by Country (2015-2020)
        7.2.2 North America Anti-Migraine Drugs Revenue by Country (2015-2020)
        7.2.3 U.S.
        7.2.4 Canada

8 Europe
    8.1 Europe Anti-Migraine Drugs Market Size YoY Growth 2015-2026
    8.2 Europe Anti-Migraine Drugs Market Facts & Figures by Country
        8.2.1 Europe Anti-Migraine Drugs Sales by Country
        8.2.2 Europe Anti-Migraine Drugs Revenue by Country
        8.2.3 Germany
        8.2.4 France
        8.2.5 U.K.
        8.2.6 Italy
        8.2.7 Russia

9 Asia Pacific
    9.1 Asia Pacific Anti-Migraine Drugs Market Size YoY Growth 2015-2026
    9.2 Asia Pacific Anti-Migraine Drugs Market Facts & Figures by Country
        9.2.1 Asia Pacific Anti-Migraine Drugs Sales by Region (2015-2020)
        9.2.2 Asia Pacific Anti-Migraine Drugs Revenue by Region
        9.2.3 China
        9.2.4 Japan
        9.2.5 South Korea
        9.2.6 India
        9.2.7 Australia
        9.2.8 Taiwan
        9.2.9 Indonesia
        9.2.10 Thailand
        9.2.11 Malaysia
        9.2.12 Philippines
        9.2.13 Vietnam

10 Latin America
    10.1 Latin America Anti-Migraine Drugs Market Size YoY Growth 2015-2026
    10.2 Latin America Anti-Migraine Drugs Market Facts & Figures by Country
        10.2.1 Latin America Anti-Migraine Drugs Sales by Country
        10.2.2 Latin America Anti-Migraine Drugs Revenue by Country
        10.2.3 Mexico
        10.2.4 Brazil
        10.2.5 Argentina

11 Middle East and Africa
    11.1 Middle East and Africa Anti-Migraine Drugs Market Size YoY Growth 2015-2026
    11.2 Middle East and Africa Anti-Migraine Drugs Market Facts & Figures by Country
        11.2.1 Middle East and Africa Anti-Migraine Drugs Sales by Country
        11.2.2 Middle East and Africa Anti-Migraine Drugs Revenue by Country
        11.2.3 Turkey
        11.2.4 Saudi Arabia
        11.2.5 U.A.E

12 Company Profiles
    12.1 Eli Lilly
        12.1.1 Eli Lilly Corporation Information
        12.1.2 Eli Lilly Description and Business Overview
        12.1.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
        12.1.4 Eli Lilly Anti-Migraine Drugs Products Offered
        12.1.5 Eli Lilly Recent Development
    12.2 Abbott Laboratories
        12.2.1 Abbott Laboratories Corporation Information
        12.2.2 Abbott Laboratories Description and Business Overview
        12.2.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
        12.2.4 Abbott Laboratories Anti-Migraine Drugs Products Offered
        12.2.5 Abbott Laboratories Recent Development
    12.3 Eisai
        12.3.1 Eisai Corporation Information
        12.3.2 Eisai Description and Business Overview
        12.3.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
        12.3.4 Eisai Anti-Migraine Drugs Products Offered
        12.3.5 Eisai Recent Development
    12.4 Allergan
        12.4.1 Allergan Corporation Information
        12.4.2 Allergan Description and Business Overview
        12.4.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
        12.4.4 Allergan Anti-Migraine Drugs Products Offered
        12.4.5 Allergan Recent Development
    12.5 Endo
        12.5.1 Endo Corporation Information
        12.5.2 Endo Description and Business Overview
        12.5.3 Endo Sales, Revenue and Gross Margin (2015-2020)
        12.5.4 Endo Anti-Migraine Drugs Products Offered
        12.5.5 Endo Recent Development
    12.6 GlaxoSmithKline
        12.6.1 GlaxoSmithKline Corporation Information
        12.6.2 GlaxoSmithKline Description and Business Overview
        12.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
        12.6.4 GlaxoSmithKline Anti-Migraine Drugs Products Offered
        12.6.5 GlaxoSmithKline Recent Development
    12.7 Impax Laboratories
        12.7.1 Impax Laboratories Corporation Information
        12.7.2 Impax Laboratories Description and Business Overview
        12.7.3 Impax Laboratories Sales, Revenue and Gross Margin (2015-2020)
        12.7.4 Impax Laboratories Anti-Migraine Drugs Products Offered
        12.7.5 Impax Laboratories Recent Development
    12.8 Pfizer
        12.8.1 Pfizer Corporation Information
        12.8.2 Pfizer Description and Business Overview
        12.8.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
        12.8.4 Pfizer Anti-Migraine Drugs Products Offered
        12.8.5 Pfizer Recent Development
    12.9 AstraZeneca
        12.9.1 AstraZeneca Corporation Information
        12.9.2 AstraZeneca Description and Business Overview
        12.9.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
        12.9.4 AstraZeneca Anti-Migraine Drugs Products Offered
        12.9.5 AstraZeneca Recent Development
    12.10 Bayer
        12.10.1 Bayer Corporation Information
        12.10.2 Bayer Description and Business Overview
        12.10.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
        12.10.4 Bayer Anti-Migraine Drugs Products Offered
        12.10.5 Bayer Recent Development
    12.11 Eli Lilly
        12.11.1 Eli Lilly Corporation Information
        12.11.2 Eli Lilly Description and Business Overview
        12.11.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
        12.11.4 Eli Lilly Anti-Migraine Drugs Products Offered
        12.11.5 Eli Lilly Recent Development
    12.12 Merck
        12.12.1 Merck Corporation Information
        12.12.2 Merck Description and Business Overview
        12.12.3 Merck Sales, Revenue and Gross Margin (2015-2020)
        12.12.4 Merck Products Offered
        12.12.5 Merck Recent Development
    12.13 Teva
        12.13.1 Teva Corporation Information
        12.13.2 Teva Description and Business Overview
        12.13.3 Teva Sales, Revenue and Gross Margin (2015-2020)
        12.13.4 Teva Products Offered
        12.13.5 Teva Recent Development
    12.14 Amgen
        12.14.1 Amgen Corporation Information
        12.14.2 Amgen Description and Business Overview
        12.14.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
        12.14.4 Amgen Products Offered
        12.14.5 Amgen Recent Development

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    13.1 Market Opportunities and Drivers
    13.2 Market Challenges
    13.3 Market Risks/Restraints
    13.4 Porter's Five Forces Analysis
    13.5 Primary Interviews with Key Anti-Migraine Drugs Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
    14.1 Value Chain Analysis
    14.2 Anti-Migraine Drugs Customers
    14.3 Sales Channels Analysis
        14.3.1 Sales Channels
        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
    16.1 Research Methodology
        16.1.1 Methodology/Research Approach
        16.1.2 Data Source
    16.2 Author Details
    16.3 Disclaimer

List of Tables Table 1. Anti-Migraine Drugs Market Segments Table 2. Ranking of Global Top Anti-Migraine Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 3. Global Anti-Migraine Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million) Table 4. Major Manufacturers of Triptans Table 5. Major Manufacturers of Ergots Table 6. Major Manufacturers of Others Table 7. Global Anti-Migraine Drugs Market Size Growth Rate by Application 2020-2026 (K Units) Table 8. Global Anti-Migraine Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026 Table 9. Global Anti-Migraine Drugs Sales by Regions 2015-2020 (K Units) Table 10. Global Anti-Migraine Drugs Sales Market Share by Regions (2015-2020) Table 11. Global Anti-Migraine Drugs Revenue by Regions 2015-2020 (US$ Million) Table 12. Global Anti-Migraine Drugs Sales Forecast by Region (2021-2026) (K Units) Table 13. Global Anti-Migraine Drugs Sales by Manufacturers (2015-2020) (K Units) Table 14. Global Anti-Migraine Drugs Sales Share by Manufacturers (2015-2020) Table 15. Global Anti-Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020) Table 16. Global Anti-Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-Migraine Drugs as of 2019) Table 17. Anti-Migraine Drugs Revenue by Manufacturers (2015-2020) (US$ Million) Table 18. Anti-Migraine Drugs Revenue Share by Manufacturers (2015-2020) Table 19. Key Manufacturers Anti-Migraine Drugs Price (2015-2020) (USD/Pcs) Table 20. Anti-Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters Table 21. Manufacturers Anti-Migraine Drugs Product Type Table 22. Date of International Manufacturers Enter into Anti-Migraine Drugs Market Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans Table 24. Global Anti-Migraine Drugs Sales by Type (2015-2020) (K Units) Table 25. Global Anti-Migraine Drugs Sales Share by Type (2015-2020) Table 26. Global Anti-Migraine Drugs Revenue by Type (2015-2020) (US$ Million) Table 27. Global Anti-Migraine Drugs Revenue Share by Type (2015-2020) Table 28. Anti-Migraine Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs) Table 29. Global Anti-Migraine Drugs Sales Share by Type (2021-2026) Table 30. Global Anti-Migraine Drugs Sales by Application (2015-2020) (K Units) Table 31. Global Anti-Migraine Drugs Sales Share by Application (2015-2020) Table 32. Global Anti-Migraine Drugs Sales Share by Application (2021-2026) Table 33. Global Anti-Migraine Drugs Sales Market Share Forecast by Application (2021-2026) Table 34. Global Anti-Migraine Drugs Revenue by Application (2015-2020) (US$ Million) Table 35. Global Anti-Migraine Drugs Revenue Market Share Forecast by Application (2021-2026) Table 36. Japan Anti-Migraine Drugs Sales (K Units) of Key Companies (2015-2020) Table 37. Japan Anti-Migraine Drugs Sales Share by Company (2015-2020) Table 38. Japan Anti-Migraine Drugs Revenue (US$ Million) by Company (2015-2020) Table 39. Japan Anti-Migraine Drugs Sales (K Units) by Type (2015-2020) Table 40. Japan Anti-Migraine Drugs Sales Share by Type (2015-2020) Table 41. Japan Anti-Migraine Drugs Revenue (US$ Million) Market Share by Type (2015-2020) Table 42. Japan Anti-Migraine Drugs Price (K Units) by Type (2015-2020) Table 43. Japan Anti-Migraine Drugs Sales (K Units) by Type (2021-2026) Table 44. Japan Anti-Migraine Drugs Sales Share by Type (2021-2026) Table 45. Japan Anti-Migraine Drugs Revenue (US$ Million) Market Share by Type (2021-2026) Table 46. Japan Anti-Migraine Drugs Revenue Share by Type (2021-2026) Table 47. Japan Anti-Migraine Drugs Price (K Units) by Type (2021-2026) Table 48. Japan Anti-Migraine Drugs Sales (K Units) by Application (2015-2020) Table 49. Japan Anti-Migraine Drugs Sales Share by Application (2015-2020) Table 50. Japan Anti-Migraine Drugs Revenue (US$ Million) Market Share by Application (2015-2020) Table 51. Japan Anti-Migraine Drugs Sales (K Units) by Application (2021-2026) Table 52. Japan Anti-Migraine Drugs Sales Share by Application (2021-2026) Table 53. Japan Anti-Migraine Drugs Revenue (US$ Million) Market Share by Application (2021-2026) Table 54. Japan Anti-Migraine Drugs Revenue Share by Application (2021-2026) Table 55. North America Anti-Migraine Drugs Sales by Country (2015-2020) (K Units) Table 56. North America Anti-Migraine Drugs Sales Market Share by Country (2015-2020) Table 57. North America Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million) Table 58. North America Anti-Migraine Drugs Revenue Market Share by Country (2015-2020) Table 59. Europe Anti-Migraine Drugs Sales by Country (2015-2020) (K Units) Table 60. Europe Anti-Migraine Drugs Sales Market Share by Country (2015-2020) Table 61. Europe Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million) Table 62. Europe Anti-Migraine Drugs Revenue Market Share by Country (2015-2020) Table 63. Asia Pacific Anti-Migraine Drugs Sales by Region (2015-2020) (K Units) Table 64. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region (2015-2020) Table 65. Asia Pacific Anti-Migraine Drugs Revenue by Region (2015-2020) (US$ Million) Table 66. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region (2015-2020) Table 67. Latin America Anti-Migraine Drugs Sales by Country (2015-2020) (K Units) Table 68. Latin America Anti-Migraine Drugs Sales Market Share by Country (2015-2020) Table 69. Latin Americaa Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million) Table 70. Latin America Anti-Migraine Drugs Revenue Market Share by Country (2015-2020) Table 71. Middle East and Africa Anti-Migraine Drugs Sales by Country (2015-2020) (K Units) Table 72. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country (2015-2020) Table 73. Middle East and Africa Anti-Migraine Drugs Revenue by Country (2015-2020) (US$ Million) Table 74. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country (2015-2020) Table 75. Eli Lilly Corporation Information Table 76. Eli Lilly Description and Business Overview Table 77. Eli Lilly Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 78. Eli Lilly Anti-Migraine Drugs Product Table 79. Eli Lilly Recent Development Table 80. Abbott Laboratories Corporation Information Table 81. Abbott Laboratories Description and Business Overview Table 82. Abbott Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 83. Abbott Laboratories Product Table 84. Abbott Laboratories Recent Development Table 85. Eisai Corporation Information Table 86. Eisai Description and Business Overview Table 87. Eisai Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 88. Eisai Product Table 89. Eisai Recent Development Table 90. Allergan Corporation Information Table 91. Allergan Description and Business Overview Table 92. Allergan Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 93. Allergan Product Table 94. Allergan Recent Development Table 95. Endo Corporation Information Table 96. Endo Description and Business Overview Table 97. Endo Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 98. Endo Product Table 99. Endo Recent Development Table 100. GlaxoSmithKline Corporation Information Table 101. GlaxoSmithKline Description and Business Overview Table 102. GlaxoSmithKline Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 103. GlaxoSmithKline Product Table 104. GlaxoSmithKline Recent Development Table 105. Impax Laboratories Corporation Information Table 106. Impax Laboratories Description and Business Overview Table 107. Impax Laboratories Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 108. Impax Laboratories Product Table 109. Impax Laboratories Recent Development Table 110. Pfizer Corporation Information Table 111. Pfizer Description and Business Overview Table 112. Pfizer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 113. Pfizer Product Table 114. Pfizer Recent Development Table 115. AstraZeneca Corporation Information Table 116. AstraZeneca Description and Business Overview Table 117. AstraZeneca Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 118. AstraZeneca Product Table 119. AstraZeneca Recent Development Table 120. Bayer Corporation Information Table 121. Bayer Description and Business Overview Table 122. Bayer Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 123. Bayer Product Table 124. Bayer Recent Development Table 125. Johnson & Johnson Corporation Information Table 126. Johnson & Johnson Description and Business Overview Table 127. Johnson & Johnson Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 128. Johnson & Johnson Product Table 129. Johnson & Johnson Recent Development Table 130. Merck Corporation Information Table 131. Merck Description and Business Overview Table 132. Merck Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 133. Merck Product Table 134. Merck Recent Development Table 135. Teva Corporation Information Table 136. Teva Description and Business Overview Table 137. Teva Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 138. Teva Product Table 139. Teva Recent Development Table 140. Amgen Corporation Information Table 141. Amgen Description and Business Overview Table 142. Amgen Anti-Migraine Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020) Table 143. Amgen Product Table 144. Amgen Recent Development Table 145. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 146. Key Challenges Table 147. Market Risks Table 148. Main Points Interviewed from Key Anti-Migraine Drugs Players Table 149. Anti-Migraine Drugs Customers List Table 150. Anti-Migraine Drugs Distributors List Table 151. Research Programs/Design for This Report Table 152. Key Data Information from Secondary Sources Table 153. Key Data Information from Primary Sources List of Figures Figure 1. Anti-Migraine Drugs Product Picture Figure 2. Global Anti-Migraine Drugs Sales Market Share by Type in 2020 & 2026 Figure 3. Triptans Product Picture Figure 4. Ergots Product Picture Figure 5. Others Product Picture Figure 6. Global Anti-Migraine Drugs Sales Market Share by Application in 2020 & 2026 Figure 7. Women Figure 8. Men Figure 9. Anti-Migraine Drugs Report Years Considered Figure 10. Global Anti-Migraine Drugs Market Size 2015-2026 (US$ Million) Figure 11. Global Anti-Migraine Drugs Sales 2015-2026 (K Units) Figure 12. Global Anti-Migraine Drugs Market Size Market Share by Region: 2020 Versus 2026 Figure 13. Global Anti-Migraine Drugs Sales Market Share by Region (2015-2020) Figure 14. Global Anti-Migraine Drugs Sales Market Share by Region in 2019 Figure 15. Global Anti-Migraine Drugs Revenue Market Share by Region (2015-2020) Figure 16. Global Anti-Migraine Drugs Revenue Market Share by Region in 2019 Figure 17. Global Anti-Migraine Drugs Sales Share by Manufacturer in 2019 Figure 18. The Top 10 and 5 Players Market Share by Anti-Migraine Drugs Revenue in 2019 Figure 19. Anti-Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 20. Global Anti-Migraine Drugs Sales Market Share by Type (2015-2020) Figure 21. Global Anti-Migraine Drugs Sales Market Share by Type in 2019 Figure 22. Global Anti-Migraine Drugs Revenue Market Share by Type (2015-2020) Figure 23. Global Anti-Migraine Drugs Revenue Market Share by Type in 2019 Figure 24. Global Anti-Migraine Drugs Market Share by Price Range (2015-2020) Figure 25. Global Anti-Migraine Drugs Sales Market Share by Application (2015-2020) Figure 26. Global Anti-Migraine Drugs Sales Market Share by Application in 2019 Figure 27. Global Anti-Migraine Drugs Revenue Market Share by Application (2015-2020) Figure 28. Global Anti-Migraine Drugs Revenue Market Share by Application in 2019 Figure 29. Japan Anti-Migraine Drugs Sales Growth Rate 2015-2026 (K Units) Figure 30. Japan Anti-Migraine Drugs Revenue Growth Rate 2015-2026 (US$ Million) Figure 31. Japan Anti-Migraine Drugs Market Share in Global Market 2015-2026 Figure 32. Japan 5 and 10 Largest Anti-Migraine Drugs Players Market Share by Revenue in Anti-Migraine Drugs in 2019 Figure 33. Japan Anti-Migraine Drugs Revenue Share by Type (2015-2020) Figure 34. Japan Anti-Migraine Drugs Revenue Growth Rate by Type in 2015 & 2019 Figure 35. Japan Anti-Migraine Drugs Revenue Share by Application (2015-2020) Figure 36. Japan Anti-Migraine Drugs Revenue Growth Rate by Application in 2015 & 2019 Figure 37. North America Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units) Figure 38. North America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 39. North America Anti-Migraine Drugs Sales Market Share by Country in 2019 Figure 40. North America Anti-Migraine Drugs Revenue Market Share by Country in 2019 Figure 41. U.S. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 42. U.S. Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 43. Canada Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 44. Canada Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Europe Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units) Figure 46. Europe Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 47. Europe Anti-Migraine Drugs Sales Market Share by Country in 2019 Figure 48. Europe Anti-Migraine Drugs Revenue Market Share by Country in 2019 Figure 49. Germany Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 50. Germany Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. France Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 52. France Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. U.K. Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 54. U.K. Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Italy Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 56. Italy Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Russia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 58. Russia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Asia Pacific Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units) Figure 60. Asia Pacific Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 61. Asia Pacific Anti-Migraine Drugs Sales Market Share by Region in 2019 Figure 62. Asia Pacific Anti-Migraine Drugs Revenue Market Share by Region in 2019 Figure 63. China Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 64. China Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Japan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 66. Japan Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 67. South Korea Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 68. South Korea Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. India Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 70. India Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Australia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 72. Australia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Taiwan Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 74. Taiwan Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 75. Indonesia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 76. Indonesia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Thailand Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 78. Thailand Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. Malaysia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 80. Malaysia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Philippines Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 82. Philippines Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 83. Vietnam Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 84. Vietnam Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 85. Latin America Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units) Figure 86. Latin America Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 87. Latin America Anti-Migraine Drugs Sales Market Share by Country in 2019 Figure 88. Latin America Anti-Migraine Drugs Revenue Market Share by Country in 2019 Figure 89. Mexico Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 90. Mexico Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 91. Brazil Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 92. Brazil Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 93. Argentina Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 94. Argentina Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 95. Middle East and Africa Anti-Migraine Drugs Sales Growth Rate 2015-2020 (K Units) Figure 96. Middle East and Africa Anti-Migraine Drugs Revenue Growth Rate 2015-2020 (US$ Million) Figure 97. Middle East and Africa Anti-Migraine Drugs Sales Market Share by Country in 2019 Figure 98. Middle East and Africa Anti-Migraine Drugs Revenue Market Share by Country in 2019 Figure 99. Turkey Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 100. Turkey Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 101. Saudi Arabia Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 102. Saudi Arabia Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 103. U.A.E Anti-Migraine Drugs Sales Growth Rate (2015-2020) (K Units) Figure 104. U.A.E Anti-Migraine Drugs Revenue Growth Rate (2015-2020) (US$ Million) Figure 105. Porter's Five Forces Analysis Figure 106. Anti-Migraine Drugs Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

New Pharmaceuticals and Healthcare Reports

Internal Neuromodulation Market Forecast 2025 | Global Report

Rising number of patients suffering from neurological disorders such as Parkinson’s, essential tremor, and primary dystonia is fueling the demand for internal neuromodulation procedures. Chronic back and leg pain associated with PVD (peripheral...

Gastrointestinal Cancer Treatment Market Size 2020-2025 | Growth Forecasts

As per credible projections, gastrointestinal cancer treatment industry is expected to register strong CAGR over 2019-2025. Rising adoption of unhealthy eating habits and increasing consumption of tobacco and alcohol have increased the pervasiveness ...

Topotecan Hydrochloride Market Trends and Research Insights by 2025

As per credible estimates, global topotecan hydrochloride market is poised to acquire commendable gains by the year 2025. Rising adoption of unhealthy and sedentary lifestyle has increased the pervasiveness of small cell lung cancer, ovarian cancer, ...

Flu Vaccine Market Share 2020-2025 | Global Industry Report

As per trusted estimates, global flu vaccine market will record substantial growth during 2020-2025. Increasing government initiatives to ensure the safety of the populace, minimal side-effects associated with influenza vaccines, improving efficacy o...

Healthcare Linen Market Size - Industry Trends Report 2025

According to reliable projections, global healthcare linen market is projected to record considerable growth during 2020-2025. Rising prevalence of various diseases including cardiovascular diseases, cancer, and arthritis along with increasing cases ...

Other Reports by QY Research

Global and United States Boric Acid Compound Market Insights, Forecast to 2026

Boric Acid Compound market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Boric Acid Compound market will be able to gain the upper hand as they use the report as a ...

Global and Japan Bone Densitometers Devices Market Insights, Forecast to 2026

Bone Densitometers Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bone Densitometers Devices market will be able to gain the upper hand as they use th...

Global and Japan Blu-ray Media Market Size, Status and Forecast 2020-2026

Global Blu-ray Media Scope and Market Size Blu-ray Media market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Blu-ray Media market will be able to gain the upper hand as they use the report as ...

Global and China Blu-ray Devices Market Insights, Forecast to 2026

Blu-ray Devices market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Blu-ray Devices market will be able to gain the upper hand as they use the report as a powerful...

Global and United States Blood Donor Armchair Market Insights, Forecast to 2026

Blood Donor Armchair market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Blood Donor Armchair market will be able to gain the upper hand as they use the report as ...

Publisher: QY Research
Chat with us